ICD-10 Code for Post-Treatment H. pylori Eradication Testing
Use ICD-10 code Z87.19 (Personal history of other diseases of the digestive system) or Z09 (Encounter for follow-up examination after completed treatment for conditions other than malignant neoplasm) for repeat H. pylori testing to confirm eradication after treatment.
Coding Rationale
The appropriate ICD-10 coding for post-treatment H. pylori eradication testing depends on the clinical context:
Primary Code Options:
Z87.19 - This code captures the personal history of H. pylori infection and is appropriate when documenting the patient's history of treated infection during follow-up testing
Z09 - This code specifically addresses follow-up examination after completed treatment for non-malignant conditions, which directly applies to post-eradication testing
B96.81 (Helicobacter pylori as the cause of diseases classified elsewhere) - Can be used if there is concern for persistent infection or if the test is being done to rule out active infection
Clinical Context for Testing
Post-treatment eradication testing is clinically indicated and should be performed universally after H. pylori treatment 1, 2. The guidelines emphasize that:
- Testing should occur at least 4 weeks after completion of therapy 1
- Patients must be off proton pump inhibitors for at least 2 weeks before testing to avoid false-negative results 1
- Urea breath test (UBT) or stool antigen test are the preferred noninvasive methods for confirming eradication 1, 2
Important Coding Caveat
Do NOT use ICD-10 code 041.86 (the ICD-9 equivalent was for active H. pylori infection) for post-treatment testing, as this implies active infection rather than follow-up testing. The ICD-10 equivalent B96.81 should only be used if there is clinical suspicion of persistent or recurrent infection 3.
Insurance Coverage Considerations
When submitting claims, pair the appropriate ICD-10 code with:
- The specific test being ordered (UBT or stool antigen)
- Documentation that this is post-treatment eradication testing
- Note that serology should NOT be used for eradication testing as it remains positive long after successful treatment (the "serologic scar") and is generally not reimbursed by Medicare 1